Therapeutic potential of WKYMVm in diseases

The synthetic hexapeptide WKYMVm, screened from a synthetic peptide library, has been identified as an agonist of FPRs with the strongest activating effect on FPR2. WKYMVm plays an anti-inflammatory role in most inflammatory diseases by increasing the chemotaxis of phagocytes and regulating the secr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Huan, Guo, Xiaoming, Wang, Zhiguo, Han, Mei, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479759/
https://www.ncbi.nlm.nih.gov/pubmed/36120322
http://dx.doi.org/10.3389/fphar.2022.986963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479759/
https://www.ncbi.nlm.nih.gov/pubmed/36120322
http://dx.doi.org/10.3389/fphar.2022.986963

Ejemplares similares